Total Payments
$6,841
2024 Payments
$1,441
Companies
48
Transactions
335
Medicare Patients
3,971
Medicare Billing
$611,302
Payment Breakdown by Category
Food & Beverage$6,750 (98.7%)
Education$73.34 (1.1%)
Other$18.04 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,750 | 331 | 98.7% |
| Education | $73.34 | 3 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18.04 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $776.86 | 54 | $0 (2024) |
| ABBVIE INC. | $742.97 | 46 | $0 (2024) |
| UCB, Inc. | $557.33 | 18 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $405.21 | 22 | $0 (2024) |
| Biogen, Inc. | $398.97 | 13 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $396.56 | 19 | $0 (2024) |
| SK Life Science, Inc. | $296.83 | 12 | $0 (2024) |
| Genentech USA, Inc. | $294.26 | 12 | $0 (2024) |
| Allergan, Inc. | $285.97 | 13 | $0 (2022) |
| PFIZER INC. | $262.35 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,441 | 66 | PFIZER INC. ($239.06) |
| 2023 | $1,359 | 59 | SK Life Science, Inc. ($169.08) |
| 2022 | $1,193 | 72 | ABBVIE INC. ($307.39) |
| 2021 | $1,123 | 63 | AbbVie Inc. ($177.94) |
| 2020 | $405.87 | 20 | Allergan, Inc. ($90.97) |
| 2019 | $619.46 | 23 | Biogen, Inc. ($123.57) |
| 2018 | $216.44 | 12 | Medtronic USA, Inc. ($55.10) |
| 2017 | $482.41 | 20 | UCB, Inc. ($179.07) |
All Payment Transactions
335 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Neuropsychiatry | ||||||
| 11/26/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.36 | General |
| 11/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Neurology | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Neuropsychiatry | ||||||
| 11/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $2.70 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological), INBRIJA | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Musculoskeletal | ||||||
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Rare Disease | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: PAIN | ||||||
| 10/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/16/2024 | Chiesi USA, Inc. | — | Food and Beverage | In-kind items and services | $65.00 | General |
| 10/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: PAIN | ||||||
| 10/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Neurology | ||||||
| 10/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: Neuropsychiatry | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Neurology | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Neurology | ||||||
| 09/27/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.88 | General |
| Category: Neuroscience | ||||||
| 09/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: PAIN | ||||||
| 09/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: Neurology | ||||||
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Rare Disease | ||||||
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,148 | 1,874 | $467,312 | $186,689 |
| 2022 | 14 | 1,043 | 1,590 | $403,971 | $158,788 |
| 2021 | 12 | 905 | 1,375 | $324,966 | $131,730 |
| 2020 | 15 | 875 | 5,863 | $348,963 | $134,095 |
Total Patients
3,971
Total Services
10,702
Medicare Billing
$611,302
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2022 | 16 | 16 | $3,456 | $1,332 | 38.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 142 | 324 | $73,308 | $29,020 | 39.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 203 | 375 | $59,243 | $23,448 | 39.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 115 | 116 | $51,033 | $19,407 | 38.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 119 | 179 | $42,960 | $18,537 | 43.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 74 | $23,852 | $11,054 | 46.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 78 | 83 | $24,571 | $9,219 | 37.5% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 99 | 114 | $13,543 | $5,806 | 42.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 28 | 28 | $12,761 | $5,554 | 43.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $10,904 | $4,514 | 41.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 19 | 27 | $5,692 | $2,514 | 44.2% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 13 | 13 | $4,506 | $1,605 | 35.6% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2021 | 12 | 12 | $2,592 | $1,050 | 40.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 211 | 506 | $79,938 | $31,582 | 39.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 13 | 4,540 | $54,480 | $22,012 | 40.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 99 | 174 | $39,369 | $15,804 | 40.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 129 | 177 | $42,480 | $14,166 | 33.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 78 | 79 | $34,755 | $13,207 | 38.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 84 | 88 | $26,052 | $10,260 | 39.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 47 | 54 | $17,405 | $6,240 | 35.9% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 30 | 46 | $9,698 | $4,174 | 43.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $10,541 | $3,783 | 35.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 19 | 19 | $8,659 | $3,342 | 38.6% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 54 | 61 | $7,247 | $3,090 | 42.6% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 38 | 43 | $6,595 | $2,179 | 33.0% |
About Dr. Nima Ramezan Arab, M.D
Dr. Nima Ramezan Arab, M.D is a Neurology healthcare provider based in Los Alamitos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699705772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nima Ramezan Arab, M.D has received a total of $6,841 in payments from pharmaceutical and medical device companies, with $1,441 received in 2024. These payments were reported across 335 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,750).
As a Medicare-enrolled provider, Ramezan Arab has provided services to 3,971 Medicare beneficiaries, totaling 10,702 services with total Medicare billing of $611,302. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Los Alamitos, CA
- Active Since 07/04/2006
- Last Updated 02/19/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1699705772
Products in Payments
- KESIMPTA (Drug) $700.17
- NURTEC ODT (Drug) $523.90
- UBRELVY (Drug) $395.51
- INGREZZA (Drug) $324.45
- BOTOX (Biological) $284.49
- QULIPTA (Drug) $223.56
- TYSABRI (Biological) $213.78
- Briviact (Drug) $209.33
- ULTOMIRIS (Biological) $201.78
- OCREVUS (Biological) $139.97
- ZEPOSIA (Drug) $136.29
- AJOVY (Biological) $128.59
- BRILINTA (Drug) $124.98
- NUPLAZID (Drug) $124.17
- Vimpat (Drug) $115.56
- XARELTO (Drug) $108.80
- EMGALITY (Drug) $102.78
- Ocrevus (Biological) $91.55
- Aimovig (Biological) $87.78
- SOLIRIS (Biological) $82.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Los Alamitos
Dr. Nirav Patel, M.d, M.D
Neurology — Payments: $848,036
Neurology $848,036
Dr. Omid Omidvar, M.d, M.D
Neurology — Payments: $33,376
Neurology $33,376
Dr. David Rosenberg, M.d, M.D
Neurology — Payments: $10,685
Neurology $10,685
Yamin Shwe, Md, MD
Neurology — Payments: $4,909
Neurology $4,909
Alan Cohen, M.d, M.D
Neurology — Payments: $3,717
Neurology $3,717
Dr. Mohan Tadikonda, M.d, M.D
Neurology — Payments: $247.80
Neurology $247.80